These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28325846)

  • 21. Perturbations of BMP/TGF-β and VEGF/VEGFR signalling pathways in non-syndromic sporadic brain arteriovenous malformations (BAVM).
    Wang K; Zhao S; Liu B; Zhang Q; Li Y; Liu J; Shen Y; Ding X; Lin J; Wu Y; Yan Z; Chen J; Li X; Song X; Niu Y; Liu J; Chen W; Ming Y; Du R; Chen C; Long B; Zhang Y; Tong X; Zhang S; Posey JE; Zhang B; Wu Z; Wythe JD; Liu P; Lupski JR; Yang X; Wu N
    J Med Genet; 2018 Oct; 55(10):675-684. PubMed ID: 30120215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CNS resident macrophages enhance dysfunctional angiogenesis and circulating monocytes infiltration in brain arteriovenous malformation.
    Ma L; Zhu X; Tang C; Pan P; Yadav A; Liang R; Press K; Nelson J; Su H
    J Cereb Blood Flow Metab; 2024 Jun; 44(6):925-937. PubMed ID: 38415628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic Correction of Murine Glycogen Storage Disease Type IV by an AAV-Mediated Gene Therapy.
    Yi H; Zhang Q; Brooks ED; Yang C; Thurberg BL; Kishnani PS; Sun B
    Hum Gene Ther; 2017 Mar; 28(3):286-294. PubMed ID: 27832700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 2 Expression in Brain Arteriovenous Malformations and its Association with Brain Arteriovenous Malformation Size.
    Neyazi B; Tanrikulu L; Wilkens L; Hartmann C; Stein KP; Dumitru CA; Sandalcioglu IE
    World Neurosurg; 2017 Jun; 102():79-84. PubMed ID: 28279775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lethality in an anti-angiogenic tumor gene therapy model upon constitutive but not inducible expression of the soluble vascular endothelial growth factor receptor 1.
    Sivanandam VG; Stephen SL; Hernandez-Alcoceba R; Alzuguren P; Zabala M; van Rooijen N; Qian C; Berger I; Gross ML; Prieto J; Kochanek S
    J Gene Med; 2008 Oct; 10(10):1083-91. PubMed ID: 18720430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function.
    Jin J; Sison K; Li C; Tian R; Wnuk M; Sung HK; Jeansson M; Zhang C; Tucholska M; Jones N; Kerjaschki D; Shibuya M; Fantus IG; Nagy A; Gerber HP; Ferrara N; Pawson T; Quaggin SE
    Cell; 2012 Oct; 151(2):384-99. PubMed ID: 23063127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic Braf
    Tu T; Yu J; Jiang C; Zhang S; Li J; Ren J; Zhang S; Zhou Y; Cui Z; Lu H; Meng X; Wang Z; Xing D; Zhang H; Hong T
    Angiogenesis; 2024 Aug; 27(3):441-460. PubMed ID: 38700584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivery of Glucosylceramidase Beta Gene Using AAV9 Vector Therapy as a Treatment Strategy in Mouse Models of Gaucher Disease.
    Du S; Ou H; Cui R; Jiang N; Zhang M; Li X; Ma J; Zhang J; Ma D
    Hum Gene Ther; 2019 Feb; 30(2):155-167. PubMed ID: 30122074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced expression of integrin alphavbeta8 is associated with brain arteriovenous malformation pathogenesis.
    Su H; Kim H; Pawlikowska L; Kitamura H; Shen F; Cambier S; Markovics J; Lawton MT; Sidney S; Bollen AW; Kwok PY; Reichardt L; Young WL; Yang GY; Nishimura SL
    Am J Pathol; 2010 Feb; 176(2):1018-27. PubMed ID: 20019187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal Behavior of the Endothelium Promoted by SMAD6 Downregulation Is Associated With Brain Arteriovenous Malformation Microhemorrhage.
    Fu W; Huo R; Yan Z; Xu H; Li H; Jiao Y; Wang L; Weng J; Wang J; Wang S; Cao Y; Zhao J
    Stroke; 2020 Jul; 51(7):2197-2207. PubMed ID: 32486965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEGFR2 Expression Correlates with Postnatal Development of Brain Arteriovenous Malformations in a Mouse Model of Type I Hereditary Hemorrhagic Telangiectasia.
    Han C; Nguyen CL; Scherschinski L; Schriber TD; Arthur HM; Lawton MT; Oh SP
    Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular Integrity in the Pathogenesis of Brain Arteriovenous Malformation.
    Zhang R; Zhu W; Su H
    Acta Neurochir Suppl; 2016; 121():29-35. PubMed ID: 26463919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting transgene to the heart and liver with AAV9 by different promoters.
    Chen BD; He CH; Chen XC; Pan S; Liu F; Ma X; Li XM; Gai MT; Tao J; Ma YT; Yang YN; Gao XM
    Clin Exp Pharmacol Physiol; 2015 Oct; 42(10):1108-17. PubMed ID: 26173818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant adeno-associated virus serotype 9 in a mouse model of atherosclerosis: Determination of the optimal expression time in vivo.
    Chen Q; Zhai H; Li X; Ma Y; Chen B; Liu F; Lai H; Xie J; He C; Luo J; Gao J; Yang Y
    Mol Med Rep; 2017 Apr; 15(4):2090-2096. PubMed ID: 28260093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations.
    Hashimoto T; Wen G; Lawton MT; Boudreau NJ; Bollen AW; Yang GY; Barbaro NM; Higashida RT; Dowd CF; Halbach VV; Young WL;
    Stroke; 2003 Apr; 34(4):925-31. PubMed ID: 12649522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attenuation of brain response to vascular endothelial growth factor-mediated angiogenesis and neurogenesis in aged mice.
    Gao P; Shen F; Gabriel RA; Law D; Yang EY; Yang GY; Young WL; Su H
    Stroke; 2009 Nov; 40(11):3596-600. PubMed ID: 19745179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis and radiobiology of brain arteriovenous malformations: implications for risk stratification in natural history and posttreatment course.
    Achrol AS; Guzman R; Varga M; Adler JR; Steinberg GK; Chang SD
    Neurosurg Focus; 2009 May; 26(5):E9. PubMed ID: 19409010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9.
    Saraiva J; Nobre RJ; Pereira de Almeida L
    J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivery of soluble VEGF receptor 1 (sFlt1) by gene electrotransfer as a new antiangiogenic cancer therapy.
    Verrax J; Defresne F; Lair F; Vandermeulen G; Rath G; Dessy C; Préat V; Feron O
    Mol Pharm; 2011 Jun; 8(3):701-8. PubMed ID: 21548585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AAVrh.10 immunogenicity in mice and humans. Relevance of antibody cross-reactivity in human gene therapy.
    Thwaite R; Pagès G; Chillón M; Bosch A
    Gene Ther; 2015 Feb; 22(2):196-201. PubMed ID: 25410741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.